Global Androgen Deprivation Therapy (ADT) Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Androgen Deprivation Therapy (ADT) Market Overview

• 1.1 Product Overview and Scope of Androgen Deprivation Therapy (ADT)
• 1.2 Classification of Androgen Deprivation Therapy (ADT) by Types
  • 1.2.1 Global Androgen Deprivation Therapy (ADT) Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Types in 2018
  • 1.2.3 Medicine
  • 1.2.4 Surgery
  • 1.2.5 Other
• 1.3 Global Androgen Deprivation Therapy (ADT) Market by Application
  • 1.3.1 Global Androgen Deprivation Therapy (ADT) Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Other
• 1.4 Global Androgen Deprivation Therapy (ADT) Market by Regions
  • 1.4.1 Global Androgen Deprivation Therapy (ADT) Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Androgen Deprivation Therapy (ADT) Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Androgen Deprivation Therapy (ADT) Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Androgen Deprivation Therapy (ADT) Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Androgen Deprivation Therapy (ADT) Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Androgen Deprivation Therapy (ADT) Status and Prospect (2014-2024)
• 1.5 Global Market Size of Androgen Deprivation Therapy (ADT) (2014-2024)

2 Company Profiles

• 2.1 Pfizer
  • 2.1.1 Business Overview
  • 2.1.2 Androgen Deprivation Therapy (ADT) Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Pfizer Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 GlaxoSmithKline
  • 2.2.1 Business Overview
  • 2.2.2 Androgen Deprivation Therapy (ADT) Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 GlaxoSmithKline Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Novartis International
  • 2.3.1 Business Overview
  • 2.3.2 Androgen Deprivation Therapy (ADT) Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Novartis International Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Astellas Pharma
  • 2.4.1 Business Overview
  • 2.4.2 Androgen Deprivation Therapy (ADT) Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Astellas Pharma Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Sanofi
  • 2.5.1 Business Overview
  • 2.5.2 Androgen Deprivation Therapy (ADT) Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Sanofi Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Johnson & Johnson
  • 2.6.1 Business Overview
  • 2.6.2 Androgen Deprivation Therapy (ADT) Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Johnson & Johnson Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Orion
  • 2.7.1 Business Overview
  • 2.7.2 Androgen Deprivation Therapy (ADT) Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Orion Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Veru
  • 2.8.1 Business Overview
  • 2.8.2 Androgen Deprivation Therapy (ADT) Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Veru Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Merck
  • 2.9.1 Business Overview
  • 2.9.2 Androgen Deprivation Therapy (ADT) Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Merck Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Bayer
  • 2.10.1 Business Overview
  • 2.10.2 Androgen Deprivation Therapy (ADT) Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Bayer Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 AstraZeneca
  • 2.11.1 Business Overview
  • 2.11.2 Androgen Deprivation Therapy (ADT) Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 AstraZeneca Androgen Deprivation Therapy (ADT) Revenue, Gross Margin and Market Share (2017-2018)

3 Global Androgen Deprivation Therapy (ADT) Market Competition, by Players

• 3.1 Global Androgen Deprivation Therapy (ADT) Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Androgen Deprivation Therapy (ADT) Players Market Share
  • 3.2.2 Top 10 Androgen Deprivation Therapy (ADT) Players Market Share
• 3.3 Market Competition Trend

4 Global Androgen Deprivation Therapy (ADT) Market Size by Regions

• 4.1 Global Androgen Deprivation Therapy (ADT) Revenue and Market Share by Regions
• 4.2 North America Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2014-2019)
• 4.3 Europe Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2014-2019)
• 4.5 South America Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2014-2019)

5 North America Androgen Deprivation Therapy (ADT) Revenue by Countries

• 5.1 North America Androgen Deprivation Therapy (ADT) Revenue by Countries (2014-2019)
• 5.2 USA Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2014-2019)
• 5.3 Canada Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2014-2019)

6 Europe Androgen Deprivation Therapy (ADT) Revenue by Countries

• 6.1 Europe Androgen Deprivation Therapy (ADT) Revenue by Countries (2014-2019)
• 6.2 Germany Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2014-2019)
• 6.3 UK Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2014-2019)
• 6.4 France Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2014-2019)
• 6.5 Russia Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2014-2019)
• 6.6 Italy Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Androgen Deprivation Therapy (ADT) Revenue by Countries

• 7.1 Asia-Pacific Androgen Deprivation Therapy (ADT) Revenue by Countries (2014-2019)
• 7.2 China Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2014-2019)
• 7.3 Japan Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2014-2019)
• 7.4 Korea Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2014-2019)
• 7.5 India Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2014-2019)

8 South America Androgen Deprivation Therapy (ADT) Revenue by Countries

• 8.1 South America Androgen Deprivation Therapy (ADT) Revenue by Countries (2014-2019)
• 8.2 Brazil Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Androgen Deprivation Therapy (ADT) by Countries

• 9.1 Middle East and Africa Androgen Deprivation Therapy (ADT) Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2014-2019)
• 9.3 UAE Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2014-2019)

10 Global Androgen Deprivation Therapy (ADT) Market Segment by Type

• 10.1 Global Androgen Deprivation Therapy (ADT) Revenue and Market Share by Type (2014-2019)
• 10.2 Global Androgen Deprivation Therapy (ADT) Market Forecast by Type (2019-2024)
• 10.3 Medicine Revenue Growth Rate (2014-2024)
• 10.4 Surgery Revenue Growth Rate (2014-2024)
• 10.5 Other Revenue Growth Rate (2014-2024)

11 Global Androgen Deprivation Therapy (ADT) Market Segment by Application

• 11.1 Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Application (2014-2019)
• 11.2 Androgen Deprivation Therapy (ADT) Market Forecast by Application (2019-2024)
• 11.3 Hospital Revenue Growth (2014-2019)
• 11.4 Clinic Revenue Growth (2014-2019)
• 11.5 Other Revenue Growth (2014-2019)

12 Global Androgen Deprivation Therapy (ADT) Market Size Forecast (2019-2024)

• 12.1 Global Androgen Deprivation Therapy (ADT) Market Size Forecast (2019-2024)
• 12.2 Global Androgen Deprivation Therapy (ADT) Market Forecast by Regions (2019-2024)
• 12.3 North America Androgen Deprivation Therapy (ADT) Revenue Market Forecast (2019-2024)
• 12.4 Europe Androgen Deprivation Therapy (ADT) Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Androgen Deprivation Therapy (ADT) Revenue Market Forecast (2019-2024)
• 12.6 South America Androgen Deprivation Therapy (ADT) Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Androgen Deprivation Therapy (ADT) Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology